Abstract 6000: Vabametkib plus lazertinib shows promising antitumor activity in advanced NSCLC with MET amplification resistant to 3rd-gen EGFR-TKIs
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Nirmal Rajasekaran, Yeongmun Kim, Dawoon Jeong, Heesoo Ahn, Jeesun Kim, Yanghee Kim, Sangsuk Lee, Sunhye Im, Young Kee Shin, Jun Young Choi, Na Young Kim
Institution: Seoul National University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409630069